Peter W. Sonsini

GLUE

Peter W. Sonsini serves as 10% Owner at Monte Rosa Therapeutics, Inc. (GLUE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$19.95M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$19.95M

Companies Traded

GLUE

Active Period

Jun 2021

1 total trades

Most Recent

Buy GLUE

Jun 30, 2021 · $19.95M

Peter W. Sonsini's Insider Trading at Monte Rosa Therapeutics, Inc. (GLUE)

Buys

1 · $19.95M

Sells

0 · $0.00

Total Shares Bought

1,050,000

Total Shares Sold

GLUE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 30, 2021↗	Buy	1,050,000	$19.00	$19.95M	7,692,300

Related Insiders

Edmund Dunn

officer: Principal Accounting Officer

GLUESell · Mar 4, 2026

Markus Warmuth

director, officer: President & CEO

GLUESell · Mar 2, 2026

Filip Janku

Chief Medical Officer

GLUESell · Feb 23, 2026

Filip Janku

officer: Chief Medical Officer

GLUESell · Feb 23, 2026

Sharon Townson

officer: Chief Scientific Officer

GLUESell · Jan 5, 2026

Jennifer Champoux

officer: Chief Operating Officer

GLUESell · Jan 5, 2026

Edmund Dunn

Principal Accounting Officer

GLUESell · Jan 5, 2026

Philip Nickson

Chief Business & Legal Officer

GLUESell · Jan 5, 2026

Explore More Insider Trading Data

GLUE Insider Trading Activity

View all insider trades at Monte Rosa Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity